INS and diabetes mellitus: In subgroup analyses, we observed MEGI to be more pronounced in patients without insulin usage at baseline, patients with well-controlled diabetes (HbA1c <7%), and patients with better kidney function (Table 3 and eTable 4 in Supplement 1).